Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Chesnara LSE:CSN London Ordinary Share GB00B00FPT80 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  +13.50p +4.02% 349.00p 2,008 09:50:52
Bid Price Offer Price High Price Low Price Open Price
338.50p 348.00p 349.00p 335.00p 335.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Life Insurance 822.99 89.60 52.38 6.7 523.0

Chesnara (CSN) Latest News

More Chesnara News
Chesnara Takeover Rumours

Chesnara (CSN) Share Charts

1 Year Chesnara Chart

1 Year Chesnara Chart

1 Month Chesnara Chart

1 Month Chesnara Chart

Intraday Chesnara Chart

Intraday Chesnara Chart

Chesnara (CSN) Discussions and Chat

Chesnara Forums and Chat

Date Time Title Posts
19/11/201512:33CHESNERA-Investor's chronicle tip for income seekers.13
23/11/200716:37Chesnara, xd. 01/04/05 fin. div. 7.1p, paid 29/04/05167
04/10/200517:38A screaming bargain3

Add a New Thread

Chesnara (CSN) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2019-01-23 17:04:42335.504,72015,835.60O
View all Chesnara trades in real-time

Chesnara (CSN) Top Chat Posts

Chesnara Daily Update: Chesnara is listed in the Life Insurance sector of the London Stock Exchange with ticker CSN. The last closing price for Chesnara was 335.50p.
Chesnara has a 4 week average price of 326p and a 12 week average price of 310.50p.
The 1 year high share price is 424.50p while the 1 year low share price is currently 310.50p.
There are currently 149,860,781 shares in issue and the average daily traded volume is 23,783 shares. The market capitalisation of Chesnara is £523,014,125.69.
jonwig: The share price here has often shown mystifying behaviour, so the question is how to value the company. Insurance accounting is still pretty opaque for me, but maybe a key number is "solvency ratio". Solvency ratio was 157% at 30/06, meaning (roughly) that it would fall to the critical 100% if supporting assets fell by 36%. Since these will be bonds rather more than equities, that's pretty unlikely. (Isn't it?) The SR has varied between 143% and 148% since end-2015. At 30/06/15 it was 271%, but that predates Solvency 2 so isn't really comparable. Another factor is FX gains/losses. Actually I don't think these matter, as SKR, say, is kept to service the Swedish arm, and changes only when account are drawn up in GBP. It's worth saying that CSN uses external fund managers (Schroders, I think), as does PHNX (SLA). They used to quote an embedded value, but that's stopped, and they now quote "Economic value" - EV per share at 30/06/18 was 467p, though this isn't a recognised measure. The company has net cash (ie. debt is irrelevant). So when FY results to 31/12 are published in March I'd be surprised if the SR fell by more that 10% (ie. to 141%), and I'd be comfortable with that.
propertyman: In view of the general uncertainty in shares, current for the time being, the results look rather appealing. The share price hasn't moved much over the past few months and that shows the business is fairly stable. I know I am investing for income and remain fairly happy about today's statement.
speedsgh: 3% increase in interim dividend offset by 3% fall in EcV means that the share price will probably at best trade sideways for the foreseeable future excepting the emergence of any unscheduled acquisition news. That is of course applying logic to the situation which in the case of the stock market is often a pointless exercise!
jonwig: Quiet lately, but we're one of IC's tips of the week. Conclusion: At 146 per cent, the group’s Solvency II ratio – of funds held over the regulatory minimum – is below that of its closest peer, Phoenix (PHNX). However, it is comfortable enough to allow the group to continue making acquisitions. Analysts at Panmure Gordon are forecasting an economic value – which includes future profit expectations from long-term policies – of 496p a share at December 2018. That followed a 3 per cent upgrade to forecasts after a strong 2017 performance. That leaves the shares trading at 0.8 times forecast economic value. Given management’s solid track record of raising the dividend – with Panmure Gordon forecasting a dividend of 20.7p a share this year, equivalent to a 5.4 per cent yield at the current share price – we think this discount is unwarranted. Buy. Last IC View: Buy, 384.5p, 4 Apr 2018
patdavey: A brief look at the long-term share price chart above suggests normal within-range movement.
solarno lopez: Any known reason for the steady decline in the share price ?
chairman20: Look at the discount in the share price as a significant buffer in case of any substantial investment markets decline. Nothing in the stock market is ever safe but CSN is an investment that allows me to sleep easy! And I like the management style - not doing anything incautious.
speedsgh: PHNX share price is still holding steady so this fall is currently looking specific to CSN. Maybe news leaking re Countrywide Assured investigation but they did state in the interims that they did not expect the outcome of the investigation to have a material impact... "The investigation into how Countrywide Assured disclosed exit fees to customers, initially announced on 3 March 2016, is ongoing. We have provided the FCA with all information requested. Discussions are ongoing and given the narrow scope of the investigation we retain our opinion that the outcome from the investigation should not have a material impact on the company."
speedsgh: CSN directors rarely buy in the open market but previous buys by the former CEO (Graham Kettleborough), though not very large, were pretty good indicators of when he thought the share price was oversold. Remains to be seen if the current CEO (John Deane) is as astute with his timing as his predecessor, if indeed he ever gets round to buying any shares! HTTP://
maddox: Hi Guys, Reading the runes..... The dividend yield is already generous and forecast increases are pretty mediocre, particularly so in view of the obvious cash accumulation. What is also crystal clear is that management have an alternative use for that cash - further acquisitions. This comes through as the primary business objective loud and clear. It is from acquisition, consolidation and cash extraction that we can expect to see share price progress. This strategy comes with a measure of uncertainty as to attractive targets being available, pricing and execution risk. In the meantime, we have that very attractive current yield to compensate us. So, nice yield and capital growth on offer - gets my vote. Regards, Maddox
Chesnara share price data is direct from the London Stock Exchange
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190124 10:14:14